Quantitative real-time PCR revealed a strong increase (32- to 293-fold) in FGFR2 mRNA levels in 2 of 26 breast tumors (∼8%) compared to a normal breast sample (Figure 7A). This evidence concerns the gene FGFR2 and breast neoplasm.